Enrollment begins at NIH Clinical Center.

A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling participants at the National Institutes of Health Clinical Center in Bethesda, Maryland. The single-site study is led by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and aims to enroll 500 people, 400 with primary or secondary immune system disorders and 100 without such conditions.… Read full story

WASHINGTON, April 23, 2021 – Super World Trading Inc., a Brooklyn, N.Y. establishment, is recalling approximately 26,270 pounds of ready-to-eat (RTE) imported Siluriformes products. The products were imported from the People’s Republic of China, a country ineligible to export processed Siluriformes products to the United States, the U.S.… Read full story

COLUMBUS, Ohio) – April 23, 2021 —Following the recommendation from the CDC’s Advisory Committee on Immunization (ACIP) today that the use of Johnson & Johnson vaccine resume in the U.S., Governor Mike DeWine has released the following statement:

“Our country’s vaccine safety system has worked as designed – these extremely rare, serious blood-clotting events were reported into the CDC’s Vaccine Adverse Event Reporting System (VAERS), and the vaccine distribution was paused to allow a thorough review of the facts and time to educate healthcare providers on the rare events.